The CDC is meeting today to discuss new limits on Johnson & Johnson’s COVID-19 vaccine over blood clotting issues:

According to the Washington Post, “the highest reporting rate of clot issues — about one case per 100,000 doses administered — has been in women 30 to 49 years old”:

And these issues have “increased since April”:

They were warned?

We’ll keep you posted.